Skip to main content
BioNTech and Pfizer's Coronavirus Vaccine Shows Potential in Human Trial - News18 02-Jul-2020
BioNTech and Pfizer's Coronavirus Vaccine Shows Potential in Human Trial - News18
BioNTech said testing of two dosages of its BNT162b1 drug on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people.
More...